Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery.

[1]  Sean M. O'Brien,et al.  Bedside Tool for Predicting the Risk of Postoperative Dialysis in Patients Undergoing Cardiac Surgery , 2006, Circulation.

[2]  Sean M. O'Brien,et al.  Impact of Renal Dysfunction on Outcomes of Coronary Artery Bypass Surgery: Results From the Society of Thoracic Surgeons National Adult Cardiac Database , 2006, Circulation.

[3]  Prevent Iv Investigators.  Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. , 2005 .

[4]  Robert M Califf,et al.  The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics. , 2005, American heart journal.

[5]  B. Hemmelgarn,et al.  Survival After Coronary Revascularization Among Patients With Kidney Disease , 2004, Circulation.

[6]  S. Borzak,et al.  Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. , 2003, The American journal of cardiology.

[7]  Robert M Califf,et al.  Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. , 2003, Journal of the American Society of Nephrology : JASN.

[8]  J. Cooper,et al.  Renal function and risk stratification in acute coronary syndromes. , 2003, The American journal of cardiology.

[9]  A. Collins,et al.  Comparative Survival of Dialysis Patients in the United States After Coronary Angioplasty, Coronary Artery Stenting, and Coronary Artery Bypass Surgery and Impact of Diabetes , 2002, Circulation.

[10]  R. Califf,et al.  Outcomes of Patients With Chronic Renal Insufficiency in the Bypass Angioplasty Revascularization Investigation , 2002, Circulation.

[11]  P. McCullough.  Cardiorenal risk: an important clinical intersection. , 2002, Reviews in cardiovascular medicine.

[12]  R. Califf,et al.  Differential survival after coronary revascularization procedures among patients with renal insufficiency. , 2001, Kidney international.

[13]  M. Pfeffer,et al.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  R. Nakamura,et al.  Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  A. Collins,et al.  A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  E L Hannan,et al.  Improving the outcomes of coronary artery bypass surgery in New York State. , 1994, JAMA.

[17]  B. Rutherford,et al.  Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. , 1990, American heart journal.

[18]  W. C. Sheldon,et al.  Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. , 1986, The New England journal of medicine.

[19]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .